Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Exploring the genetic background of normal facial variation to dissect disease expressivity, using achondroplasia as a model.

EF 2022-23

Résumé
Nearly 50% of patients with symptoms of genetic disease remain undiagnosed, hindering the appropriate management of disease. Craniofacial morphology is indicative of many genetic disorders and often contributes to diagnosis; for instance, achondroplasia is the most common cause of dwarfism and results in characteristic facial features, such as a prominent forehead and underdeveloped midface. Achondroplasia is monogenic, meaning the disorder is caused by a mutation in a single gene, fibroblast growth factor receptor 3 (Fgfr3). Despite being monogenic, achondroplasia has variable disease expressivity in that patients often exhibit different manifestations of the same disease. Understanding what contributes to this variability will improve the diagnosis and treatment of achondroplasia, and monogenic disorders in general. I hypothesize that disease severity is altered by interactions with genes that regulate normal non-syndromic facial shape. Likewise, achondroplasia severity may be regulated by normal background genetic variation. I will assess three identified candidate genes that may alter the presentation of achondroplasia using a mouse model. Craniofacial morphology of mice with mutations in both Fgfr3 and candidate genes will be analysed and measured in terms of phenotypic severity. To investigate possible molecular interactions, I will evaluate Fgfr3 expression in these mice to determine if the candidate genes regulate Fgfr3. I anticipate that candidate genes will modulate the severity of the achondroplasia phenotype and that this will provide insight into the expressivity of genetic diseases. This work will change our understanding of monogenic disorders and the role of underlying background effects in the expressivity of such disorders.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486257
Name
Tran Kristen
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the genetic background of normal facial variation to dissect disease expressivity, using achondroplasia as a model.
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Achondroplasia; Bone And Cartilage; Congenital Disease; Craniofacial Morphology; Developmental Biology; Disease Expressivity; Fibroblast Growth Factor Receptor 3; Genetic Disease; Genetics; Geometric Morphometrics
Abstract
Nearly 50% of patients with symptoms of genetic disease remain undiagnosed, hindering the appropriate management of disease. Craniofacial morphology is indicative of many genetic disorders and often contributes to diagnosis; for instance, achondroplasia is the most common cause of dwarfism and results in characteristic facial features, such as a prominent forehead and underdeveloped midface. Achondroplasia is monogenic, meaning the disorder is caused by a mutation in a single gene, fibroblast growth factor receptor 3 (Fgfr3). Despite being monogenic, achondroplasia has variable disease expressivity in that patients often exhibit different manifestations of the same disease. Understanding what contributes to this variability will improve the diagnosis and treatment of achondroplasia, and monogenic disorders in general. I hypothesize that disease severity is altered by interactions with genes that regulate normal non-syndromic facial shape. Likewise, achondroplasia severity may be regulated by normal background genetic variation. I will assess three identified candidate genes that may alter the presentation of achondroplasia using a mouse model. Craniofacial morphology of mice with mutations in both Fgfr3 and candidate genes will be analysed and measured in terms of phenotypic severity. To investigate possible molecular interactions, I will evaluate Fgfr3 expression in these mice to determine if the candidate genes regulate Fgfr3. I anticipate that candidate genes will modulate the severity of the achondroplasia phenotype and that this will provide insight into the expressivity of genetic diseases. This work will change our understanding of monogenic disorders and the role of underlying background effects in the expressivity of such disorders.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tran, Kristen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~